Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
19.02
-0.25 (-1.30%)
At close: May 20, 2025, 4:00 PM
19.11
+0.09 (0.47%)
After-hours: May 20, 2025, 4:05 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $614.58 million as of May 20, 2025. Its market cap has decreased by -18.83% in one year.
Market Cap
614.58M
Enterprise Value
284.44M
1-Year Change
-18.83%
Ranking
Category
Stock Price
$19.02
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $614.58M, an increase of 277.05%. That is a compound annual growth rate of 119.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 614.58M | -4.75% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.75B |
| Johnson & Johnson | 365.68B |
| AbbVie | 324.21B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 274.15B |
| Abbott Laboratories | 235.56B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |